Combined resynchronization therapy and automatic defibrillator in advanced non-ischaemic heart failure: The importance of QRS width

Europace

Volumn 12, Issue 1, 2010, Pages 92-95

  Cabrera Bueno, Fernando ^a,b   Fernández Pastor, Julia ^a   Molina Mora, María José ^a   Alzueta, Javier ^a   Peña Hernández, José Luis ^a   Barrera, Alberto ^a   De Teresa Galván, Eduardo ^a  

^a Hospital Clínico   (Spain)

^b NONE   (Spain)

Author keywords

Cardiomyopathy; Heart failure; Resynchronization; Ventricular arrhythmia

Indexed keywords

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART FAILURE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; QRS COMPLEX; SEX DIFFERENCE;

CARDIAC PACING, ARTIFICIAL; COMBINED MODALITY THERAPY; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROGNOSIS; RETROSPECTIVE STUDIES; THERAPY, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 73749088799     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup348     Document Type: Article

References (27)

1. Abraham WT, Fischer WG, Smith Al, Smith AL, Delurgio DB, Leon AR et al. Cardiac resynchronization therapy in chronic heart failure. N Engl J Med 2002; 346:1845-1853
2. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;12:873-880
3. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T et al. Cardiac- resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150
4. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549 (Pubitemid 40517094)
5. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J 2006;16:1928-1932
6. Di Biase L, Gasparini M, Lunati M, Santini M, Landolina M, Boriani G et al. Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy: the InSync ICD (Implantable Cardioverter- Defibrillator) Italian Registry. J Am Coll Cardiol 2008;52:1442-1449
7. Lin G, Rea RF, Hammill SC, Hayes DL, Brady PA. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices. Heart 2008;94:186-190
8. Gasparini M, Lunati M, Landolina M, Santini M, Padeletti L, Perego G et al. Electrical storm in patients with biventricular implantable cardioverter defibrillator: incidence, predictors, and prognostic implications. Am Heart J 2008;156: 847-854
9. McSwain RL, Schwartz RA, DeLurgio DB, Mera FV, Langberg JJ, León AR. The impact of cardiac resynchronization therapy on ventricular tachycardia/fibrillation: an analysis from the combined Contak-CD and InSync-ICD studies. J Cardiovasc Electrophysiol 2005;16:1168-1171
10. Higgins SL, Yong P, Sheck D, McDaniel M, Bollinger F, Vadecha M et al. Ventak CHF Investigators Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy.. J Am Coll Cardiol 2000;36:824-827
11. Ermis C, Seutter R, Zhu AX, Benditt LC, VanHeel L, Sakaguchi S et al. Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol 2005;46:2258-2263
12. Arya A, Haghjoo M, Dehghani MR, Alasti M, Alizadeh H, Kazemi B et al. Effect of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in patients with an implantable cardioverter-defibrillator. Heart Rhythm 2005;2: 1094-1098
13. Ector H, Vardas P. Current use of pacemakers, implantable cardioverter defibrillators, and resynchronization devices: data from the registry of the European Heart Rhythm Association. Eur Heart J Suppl 2007;9:I44-9
14. Markowitz SM, Lewen JM, Wiggenhorn CJ, Abraham WT, Stein KM, Iwai S et al. Relationship of reverse anatomical remodeling and ventricular arrhythmias after cardiac resynchronization. J Cardiovasc Electrophysiol 2009;20:293-298
15. Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, De Marco T et al. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. Circulation 2006;114:2766-2772
16. Field ME, Sweeney MO. Socio-economic analysis of cardiac resynchronization therapy. J Interv Card Electrophysiol 2006;17:225-236
17. Wikstrom G, Lundqvist CB, Andren B, Lönnerholm S, Blomström P, Freemantle N et al. The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial. Eur Heart J 2009; 30:782-788
18. Iuliano S, Fisher SG, Karasik PE, Fletcher RD, Singh SN. QRS duration and mortality in patients with congestive heart failure. Am Heart J 2002;143: 1085-1091
19. Silvet H, Amin J, Padmanabhan S, Pai RG. Prognostic implications of increased QRS duration in patients with moderate to severe left ventricular systolic dysfunction. Am J Cardiol 2001;88:182-185
20. Horwich T, Lee SJ, Saxon L. Usefulness of QRS prolongation in predicting risk of inducible monomorphic ventricular tachycardia in patients referred for electrophysiologic studies. Am J Cardiol 2003;92:804-809
21. Jordaens L, Tavernier R. Determinants of sudden death after discharge from hospital for myocardial infarction in the thrombolytic era. Eur Heart J 2001;22: 1214-1225
22. Bode-Schnurbus L, Böcker D, Block M, Gradaus R, Heinecke A, Breithardt G et al. QRS duration: a simple marker for predicting cardiac mortality in ICD patients with heart failure. Heart 2003;89:1157-1162
23. Stecker EC, Zargarian M, Dogra V, John BT, Kron J, McAnulty JH et al. Native QRS duration predicts the occurrence of arrhythmic events in ICD recipients. Europace 2006;8:859-862
24. Klein G, Lissel C, Fuchs AC, Gardiwal A, Oswald H, Desousa M et al. Predictors of VT/VF occurrence in ICD patients: results from the PROFIT-Study. Europace 2006;8:618-624
25. Buxton AE, Sweeney MO, Wathen MS, Josephson ME, Otterness MF, Hogan-Miller E et al. QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators. J Am Coll Cardiol 2005;46:310-316
26. Gervais R, Leclercq C, Shankar A, Jacobs S, Eiskjaer H, Johannessen A et al. Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the CARE-HF trial. Eur J Heart Fail 2009; 11:699-705
27. Yu CM, Bleeker GB, Fung JW, Schalij MJ, Zhang Q, Van Der Wall EE et al. Left ventricular reverse remodelling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 2005;112:1580-1586